BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved BPC 157 Benefits and Research Applications BPC 157: Experimental Peptide Creates Risk for Athletes BPC 157 5mg Baltic BioLabs Stable Isotope Labeling Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC 157 in Doping Control by UHPLC HRMS